DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20213046

Typhoid burden, drug resistance and Pakistan’s stance against it

Nouman Mansoor Ali, Rabail Nasr, Mehroze Rehman, Syed Uzair Mahmood

Abstract


Salmonella typhi is a gram negative, rod shaped bacteria that features a polysaccharide capsule, flagella for motility and fimbria for adhesion to the epithelial cells of intestinal mucosa. The organism is responsible for causing enteric fever and in severe cases it leads to complications such as intestinal perforation which can lead to death. The mainstay of treatment of typhoid fever is antibiotic therapy but unfortunately the emergence of MDR (multidrug resistant) and XDR (extensively drug resistant) strains pose a major threat to the successful treatment of typhoid. Around 200,000 global deaths can be associated with typhoid and most cases are seen in low socioeconomic countries with inadequate healthcare infrastructure particularly those that are densely populated, among them Pakistan is considered as high-risk country according to WHO criteria. Prevention strategies include education of the masses regarding hand hygiene, cleanliness and consumption of clean food and water. In 2019 Pakistan encountered an epidemic of XDR typhoid and to control it, Government introduced typhoid vaccine in its nationwide vaccination program, and is hopeful that it will decrease the burden of disease on state and its citizens.


Keywords


Infectious disease, Communicable disease, Typhoid, Drug resistance

Full Text:

PDF

References


Threlfall J, Ward L, Old D. Changing the nomenclature of Salmonella. Communicab Dis Public Health. 1999;2(3):156-7.

Centers for disease control and prevention. Preliminary FoodNet data on the incidence of foodborne illnesses--selected sites, United States, 2001. MMWR. 2002;51(15):325-9.

Zaki SA, Karande S. Multidrug-resistant typhoid fever: a review. J Infect. 2011;5(5):324-37.

Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Global Health. 2014;2(10):e570-80.

Antillón M, Warren JL, Crawford FW, Weinberger DM, Kürüm E, Pak GD, et al. The burden of typhoid fever in low- and middle-income countries: A meta-regression approach. PLoS one. 2017;11(2): e0005376.

Stanaway J, Reiner R, Blacker B, Goldberg E, Khalil I, Troeger C, et al. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019;19:369-81.

Qamar FN, Azmatullah A, Bhutta ZA. Challenges in measuring complications and death due to invasive Salmonella infections. Vaccine. 2015;33(3):C16-20.

Breiman RF, Cosmas L, Njuguna H, Audi A, Olack B, Ochieng JB, et al. Population-based incidence of typhoid fever in an urban informal settlement. PloS one. 2012;7(1):e29119.

Ashurst JV, Truong J, Woodbury B. Salmonella Typhi. StatPearls. United States: StatPearls Publishing. 2018.

Lindberg AA. Polyosides (encapsulated bacteria). Comptes rendus de l'Academie des sciences Serie III. Sci de la vie. 1999;322(11):925-32.

Swaddiwudhipong W, Kanlayanaphotporn J. A common-source water-borne outbreak of multidrug-resistant typhoid fever in a rural Thai community. J Med Assoc Thailand. 2001;84(11):1513-7.

Soomro S, Baig S, Naseem S, Sharafat S. Seasonal variation and recent status of Typhoid Fever in a Tertiary Care Hospital. Int J Endorsing Health Sci Res. 2014;2(2):100-3.

Hayat AS, Shaikh N, Shah SIA. Typhoid fever. Profess Med J. 2011;18(02):259-64.

Brooks WA, Hossain A, Goswami D, Sharmeen AT, Nahar K, Alam K, et al. Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis. 2005;11(2):326.

Hensel M. Evolution of pathogenicity islands of Salmonella enterica. Int J Med Microbiol. 2004; 294(2-3):95-102.

McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001;413(6858):852-6.

Bock A, Sawers G. Escherichia coli and Salmonella: Cellular and molecular biology, 2nd ed. United States: ASM Press; 1996:262-82.

Popoff MY, Bockemühl J, Brenner FW. Supplement 1999 (no. 43) to the Kauffmann-White scheme. Res Microbiol. 2000;151(10):893-6.

Perna NT, Plunkett G, Burland V, Mau B, Glasner JD, Rose DJ, et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature. 2001;409(6819):529-33.

Ochman H, Lawrence JG, Groisman EA. Lateral gene transfer and the nature of bacterial innovation. Nature. 2000;405(6784):299-304.

Marchello CS, Birkhold M, Crump JA. Complications and mortality of typhoid fever: A global systematic review and meta-analysis. J Infect. 2020;81(6):902-10.

Mintz E SS, Chaignat C. Typhoid Fever. Control of communicable diseases manual 19th ed. USA: Americal Association of Infectious disease; 2008: 664-71.

Qamar A, Ismail T, Akhtar S. Prevalence and antibiotic resistance of Salmonella spp. in South Punjab-Pakistan. PloS one. 2020;15(11):e0232382.

Essa F, Hussain SZM, Batool D, Usman A, Khalid U, Yaqoob U, et al. Study of socio-demographic factors affecting the prevalence of typhoid. Ann Med Health Sci Res. 2019;9(1):45-59.

Siddiqui TR, Bibi S, Mustufa MA, Ayaz SM, Khan A. High prevalence of typhoidal Salmonella enterica serovars excreting food handlers in Karachi-Pakistan. J Health Popul Nutr. 2015;33:27.

Crump JA. Progress in typhoid fever epidemiology. Clin Infect Dis. 2019;68(1):S4-9.

Akram J, Khan AS, Khan HA, Gilani SA, Akram SJ, Ahmad FJ, et al. Extensively drug-resistant (xdr) typhoid: evolution, prevention, and its management. BioMed Res Int. 2020;2020:6432580.

Azmatullah A, Qamar FN, Thaver D, Zaidi AK, Bhutta ZA. Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever. J Global Health. 2015;5(2):57-63.

Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Org. 2004;82:346-53.

Ochiai RL, Wang X, Von Seidlein L, Yang J, Bhutta ZA, Bhattacharya SK, et al. Salmonella paratyphi A rates, Asia. Emerg Infect Dis. 2005;11(11):1764.

Tsolis RM, Kingsley RA, Townsend SM, Ficht TA, Adams LG, Bäumler AJ. Of mice, calves, and men. Mechanism Pathogen Enteric Dis. 1999:261-74.

Santos RL, Zhang S, Tsolis RM, Kingsley RA, Adams LG, Bäumler AJ. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect. 2001;3(14-15):1335-44.

McGovern V, Slavutin L. Pathology of salmonella colitis. Am J Surg Pathol. 1979;3(6):483-90.

Day D, Mandal B, Morson B. The rectal biopsy appearances in Salmonella colitis. Histopathol. 1978; 2(2):117-31.

Harris JC, Dupont HL, Hornick RB. Fecal leukocytes in diarrheal illness. Ann Internal Med. 1972;76(5): 697-703.

Raffatellu M, Wilson RP, Winter SE, Baumler AJ. Clinical pathogenesis of typhoid fever. J Infect Develop Countries. 2008;2(04):260-6.

Jawetz E. Melnick JL AE. Review of Medical Microbiology. 12th ed LosAltos, California: Lange; 1976.

Wain J, Diep TS, Bay PVB, Walsh AL, Vinh H, Duong NM, et al. Specimens and culture media for the laboratory diagnosis of typhoid fever. J Infect Develop Countries. 2008;2(06):469-74.

Dougan G, Baker S. Salmonella enterica serovar Typhi and the pathogenesis of typhoid fever. Ann Rev Microbiol. 2014;68:317-36.

Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 1997;24(1):S106-9.

Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infecti Dis. 2010;50(2):241-6.

Vollaard AM, Ali S, van Asten HA, Widjaja S, Visser LG, Surjadi C, et al. Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA. 2004;291(21):2607-15.

Mukhopadhyay B, Sur D, Gupta SS, Ganguly NK. Typhoid fever: Control & challenges in India. Indian J Med Res. 2019;150(5):437-47.

Rasheed MK, Hasan SS, Ahmed SI. Extensively drug-resistant typhoid fever in Pakistan. Lancet Infect Dis. 2019;19(3):242-3.

Khan MI, Soofi SB, Ochiai RL, Khan MJ, Sahito SM, Habib MA, et al. Epidemiology, clinical presentation, and patterns of drug resistance. J Infect Develop Countries. 2012;6(10):704-14.

Extensively drug-resistant typhoid fever in Pakistan 2019. Available at: https://wwwnc.cdc.gov/travel/ notices/watch/xdr-typhoid-fever-pakistan. Accessed on 20 May 2021.

Pakistan first country to introduce new typhoid vaccine into routine immunization programme 2019. Available at: http://www.emro.who.int/pak/pakistan-news/pakistan-first-country-to-introduce-new-typhoid-vaccine-into-routine-immunization-programme.html. Accessed on 20 May 2021.